Efficacy and safety of oral ritlecitinib for the treatment of active nonsegmental vitiligo: A randomized phase 2b clinical trial - Concepedia

Concepedia

Publication | Open Access

Efficacy and safety of oral ritlecitinib for the treatment of active nonsegmental vitiligo: A randomized phase 2b clinical trial

DOI Full Paper Access

126

Citations

16

References

2022

Year

Khaled Ezzedine, Elena Peeva, Yuji Yamaguchi, Lori Ann Cox, Anindita Banerjee, George Han, Iltefat Hamzavi, Anand K. Ganesan, Mauro Picardo, Diamant Thaçi,

Journal of the American Academy of Dermatology

Translational MedicineActive Nonsegmental VitiligoPharmacologyOral RitlecitinibPharmacotherapyDermatologyMedicineRandomized Phase 2B

References

	Year	Citations

Page 1

Page 1